These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

468 related articles for article (PubMed ID: 24824547)

  • 1. Gut dysbiosis and detection of "live gut bacteria" in blood of Japanese patients with type 2 diabetes.
    Sato J; Kanazawa A; Ikeda F; Yoshihara T; Goto H; Abe H; Komiya K; Kawaguchi M; Shimizu T; Ogihara T; Tamura Y; Sakurai Y; Yamamoto R; Mita T; Fujitani Y; Fukuda H; Nomoto K; Takahashi T; Asahara T; Hirose T; Nagata S; Yamashiro Y; Watada H
    Diabetes Care; 2014 Aug; 37(8):2343-50. PubMed ID: 24824547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The alteration of gut microbiota in newly diagnosed type 2 diabetic patients.
    Chen PC; Chien YW; Yang SC
    Nutrition; 2019; 63-64():51-56. PubMed ID: 30933725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gut microbiota profile in healthy Indonesians.
    Rahayu ES; Utami T; Mariyatun M; Hasan PN; Kamil RZ; Setyawan RH; Pamungkaningtyas FH; Harahap IA; Wiryohanjoyo DV; Pramesi PC; Cahyanto MN; Sujaya IN; Juffrie M
    World J Gastroenterol; 2019 Mar; 25(12):1478-1491. PubMed ID: 30948911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gut Dysbiosis in Patients with Anorexia Nervosa.
    Morita C; Tsuji H; Hata T; Gondo M; Takakura S; Kawai K; Yoshihara K; Ogata K; Nomoto K; Miyazaki K; Sudo N
    PLoS One; 2015; 10(12):e0145274. PubMed ID: 26682545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fecal Microbiota in Patients with Irritable Bowel Syndrome Compared with Healthy Controls Using Real-Time Polymerase Chain Reaction: An Evidence of Dysbiosis.
    Shukla R; Ghoshal U; Dhole TN; Ghoshal UC
    Dig Dis Sci; 2015 Oct; 60(10):2953-62. PubMed ID: 25784074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gut Microbiota in Health and Disease.
    Yamashiro Y
    Ann Nutr Metab; 2017; 71(3-4):242-246. PubMed ID: 29136611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gut Microbiota Composition Before and After Use of Proton Pump Inhibitors.
    Hojo M; Asahara T; Nagahara A; Takeda T; Matsumoto K; Ueyama H; Matsumoto K; Asaoka D; Takahashi T; Nomoto K; Yamashiro Y; Watanabe S
    Dig Dis Sci; 2018 Nov; 63(11):2940-2949. PubMed ID: 29796911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Probiotic reduces bacterial translocation in type 2 diabetes mellitus: A randomised controlled study.
    Sato J; Kanazawa A; Azuma K; Ikeda F; Goto H; Komiya K; Kanno R; Tamura Y; Asahara T; Takahashi T; Nomoto K; Yamashiro Y; Watada H
    Sci Rep; 2017 Sep; 7(1):12115. PubMed ID: 28935921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gut microbiota dysbiosis in patients with non-alcoholic fatty liver disease.
    Shen F; Zheng RD; Sun XQ; Ding WJ; Wang XY; Fan JG
    Hepatobiliary Pancreat Dis Int; 2017 Aug; 16(4):375-381. PubMed ID: 28823367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Understanding the gut-kidney axis among biopsy-proven diabetic nephropathy, type 2 diabetes mellitus and healthy controls: an analysis of the gut microbiota composition.
    Tao S; Li L; Li L; Liu Y; Ren Q; Shi M; Liu J; Jiang J; Ma H; Huang Z; Xia Z; Pan J; Wei T; Wang Y; Li P; Lan T; Tang X; Zeng X; Lei S; Tang H; Ma L; Fu P
    Acta Diabetol; 2019 May; 56(5):581-592. PubMed ID: 30888537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of co-administration of probiotics with herbal medicine on obesity, metabolic endotoxemia and dysbiosis: a randomized double-blind controlled clinical trial.
    Lee SJ; Bose S; Seo JG; Chung WS; Lim CY; Kim H
    Clin Nutr; 2014 Dec; 33(6):973-81. PubMed ID: 24411490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [State of intestinal microbiota in patients with type 2 diabetes mellitus and non-alcoholic fatty liver disease].
    Lytvynenko KO; Bodnar PM; Lysiana TO; Ponomar'ova IH; Koval'chuk OA
    Lik Sprava; 2014; (5-6):82-7. PubMed ID: 25906652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of gut microbiota in adult patients with type 2 diabetes and healthy individuals.
    Sedighi M; Razavi S; Navab-Moghadam F; Khamseh ME; Alaei-Shahmiri F; Mehrtash A; Amirmozafari N
    Microb Pathog; 2017 Oct; 111():362-369. PubMed ID: 28912092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sensitive Quantitative Analysis of the Meconium Bacterial Microbiota in Healthy Term Infants Born Vaginally or by Cesarean Section.
    Nagpal R; Tsuji H; Takahashi T; Kawashima K; Nagata S; Nomoto K; Yamashiro Y
    Front Microbiol; 2016; 7():1997. PubMed ID: 28018325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alterations in the intestinal microbiome (dysbiosis) as a predictor of relapse after infliximab withdrawal in Crohn's disease.
    Rajca S; Grondin V; Louis E; Vernier-Massouille G; Grimaud JC; Bouhnik Y; Laharie D; Dupas JL; Pillant H; Picon L; Veyrac M; Flamant M; Savoye G; Jian R; Devos M; Paintaud G; Piver E; Allez M; Mary JY; Sokol H; Colombel JF; Seksik P
    Inflamm Bowel Dis; 2014 Jun; 20(6):978-86. PubMed ID: 24788220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-37 sensitize the elderly type 2 diabetic patients to insulin therapy through suppressing the gut microbiota dysbiosis.
    Li T; Li H; Li W; Chen S; Feng T; Jiao W; Wu C; Dong J; Li Y; Li S; Feng M; Wei X
    Mol Immunol; 2019 Aug; 112():322-329. PubMed ID: 31238287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of artesunate supplementation on bacterial translocation and dysbiosis of gut microbiota in rats with liver cirrhosis.
    Chen YX; Lai LN; Zhang HY; Bi YH; Meng L; Li XJ; Tian XX; Wang LM; Fan YM; Zhao ZF; Han DW; Ji C
    World J Gastroenterol; 2016 Mar; 22(10):2949-59. PubMed ID: 26973391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microbiota and diabetes: an evolving relationship.
    Tilg H; Moschen AR
    Gut; 2014 Sep; 63(9):1513-21. PubMed ID: 24833634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of gut microbiota dysbioses in type 2 diabetic patients by macrobiotic Ma-Pi 2 diet.
    Candela M; Biagi E; Soverini M; Consolandi C; Quercia S; Severgnini M; Peano C; Turroni S; Rampelli S; Pozzilli P; Pianesi M; Fallucca F; Brigidi P
    Br J Nutr; 2016 Jul; 116(1):80-93. PubMed ID: 27151248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gut microbiota dysbiosis in stable coronary artery disease combined with type 2 diabetes mellitus influences cardiovascular prognosis.
    Tian R; Liu H; Feng S; Wang H; Wang Y; Wang Y; Liang L; Xu H; Xing H; Zhang S
    Nutr Metab Cardiovasc Dis; 2021 May; 31(5):1454-1466. PubMed ID: 33810955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.